NEU 6.41% $15.27 neuren pharmaceuticals limited

Interesting comments on value. So what is people’s view on...

  1. 2,640 Posts.
    lightbulb Created with Sketch. 427
    Interesting comments on value. So what is people’s view on current value, with Trofenitide looking to earn us in the order of $100 million plus per year and likely to grow, and 3 of 4 positive phase 2 trials with a market 4 to 5 times higher than Trofenitide.

    In my view $15 doesn’t cut it - more like $20
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.